Table 4.
Acute Stroke Performance Metrics Among Different Racial‐Ethnic Groups Over Time, 2010–2014
| Percentage, AOR (95% CI)a | ||||
|---|---|---|---|---|
| FL Non‐Hispanic White | FL Non‐Hispanic Black | FL Hispanic | PR Hispanic | |
| IV tPA, arrive by 2 hours and treat by 3 hours | Ref | |||
| 2010 | 80.0 | 72.3, 0.59 (0.34–1.02) | 85.2, 1.21 (0.66–2.22) | 63.9, 1.64 (0.59–4.54) |
| 2014 | 93.7 | 96.0, 1.93 (0.93–4.03) | 97.0, 2.05 (1.14–3.68) | 66.7, 0.24 (0.06–0.90)b |
| Early antithrombotic use | Ref | |||
| 2010 | 95.6 | 93.0, 0.73 (0.60–0.90) | 91.8, 0.85 (0.60–1.19) | 94.1, 1.11 (051–2.45) |
| 2014 | 97.9 | 97.6, 0.98 (072–1.34) | 97.4, 0.96 (0.67–1.38) | 84.6, 0.11 (0.06–0.20)b |
| Antithrombotics at discharge | Ref | |||
| 2010 | 96.3 | 94.7, 0.83 (0.71–0.98) | 94.8, 0.85 (0.62–1.15) | 94.0, 0.26 (0.08–0.82)b |
| 2014 | 99.2 | 99.3, 1.19 (0.64–2.21) | 99.1, 0.85 (0.49–1.47) | 93.2, 0.20 (0.11–0.39)b |
| Anticoagulation for atrial fibrillation | Ref | |||
| 2010 | 94.0 | 95.1, 1.42 (0.57–3.58) | 90.5, 1.09 (0.46–2.60) | 94.4, 1.75 (0.56–5.49) |
| 2014 | 97.1 | 96.5, 0.75 (0.33–1.72) | 97.8, 1.60 (0.65–3.94) | 92.6, 0.72 (0.26–1.94) |
| Smoking cessation counseling | Ref | |||
| 2010 | 98.4 | 96.9, 0.48 (0.29–0.79) | 96.3, 0.75 (0.19–2.88) | 95.5, 0.71 (0.18–2.81) |
| 2014 | 97.9 | 96.8, 0.70 (0.44–1.12) | 96.9, 0.91 (0.38–2.17) | 95.2, 0.47 (0.08–2.84) |
| LDL ≥100 mg/dL or ND—Statin | Ref | |||
| 2010 | 87.8 | 87.9, 0.97 (0.85–1.11) | 86.0, 1.03 (0.84–1.26) | 78.0, 0.64 (0.23–1.75) |
| 2014 | 97.3 | 97.9, 1.22 (0.86–1.73) | 98.1, 1.13 (0.73–1.75) | 83.4, 0.16 (0.09–0.29)b |
| VTE prophylaxis | Ref | |||
| 2010 | 70.0 | 73.2, 0.98 (0.90–1.06) | 67.9, 1.08 (0.98–1.20) | 34.6, 0.58 (0.12–2.75) |
| 2014 | 97.3 | 98.1, 1.11 (0.83–1.48) | 98.0, 1.16 (0.83–1.62) | 78.7, 0.13 (0.07–0.25)b |
| Defect‐free care | Ref | |||
| 2010 | 63.1 | 65.2, 0.97 (0.89–1.05) | 58.7, 1.10 (0.99–1.23) | 30.8, 0.69 (0.18–2.73) |
| 2011 | 67.6 | 70.9, 1.02 (0.96–1.09) | 66.5, 0.96 (0.84–1.09) | 39.5, 0.63 (0.16–2.58) |
| 2012 | 83.4 | 83.3, 0.99 (0.86–1.14) | 84.1, 0.97 (0.80–1.18) | 62.8, 0.29 (0.12–0.69)b |
| 2013 | 91.1 | 91.7, 1.10 (0.92–1.32) | 92.1, 1.12 (0.96–1.30) | 76.6, 0.36 (0.19–0.68)b |
| 2014 | 92.9 | 93.7, 1.10 (0.90–1.34) | 93.5, 1.11 (0.86–1.43) | 63.1, 0.13 (0.07–0.25)b |
AOR indicates adjusted odds ratio; IV tPA, intravenous tissue plasminogen activator; LDL, low‐density lipoprotein; ND, not documented; VTE, venous thromboembolism.
a
The model is multilevel adjusted for hospital‐level random effect and age, sex, health insurance status, mode of arrival, academic status, number of beds, and years in Get With the Guidelines.
b
P<0.05 Puerto Rico (PR) Hispanics vs Florida (FL) Hispanics.